Eric B. Mosbrooker
Eric Mosbrooker joined Origin in August, 2018. Prior to Origin, Mr. Mosbrooker led the orphan business at Horizon Pharma after its acquisition of Raptor Pharmaceuticals. At Raptor, he was the senior vice president, Americas & Asia Pacific, where he led the US launch of PROCYSBI®, a drug for the treatment of nephropathic cystinosis. He has over 15 years of experience in the healthcare industry, with the majority of his tenure focused on launching and commercializing treatments for rare diseases.
Prior to Raptor, Mr. Mosbrooker served as the lead for commercial operations and market access at Alexion and Enobia Pharma, Inc. Previously, he served in various commercial operational capacities at Onyx Pharmaceuticals, Jazz Pharmaceuticals Inc., Chiron Corporation (now Novartis) and Millennium Pharmaceuticals. He also has extensive experience in management, healthcare and technology consulting at IBM, Teltech Resource Network Corporation and Kohler Company. Eric received a B.S. in industrial engineering from the University of Wisconsin, Madison.